![Christoph Bausch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: - $ per 2026-05-31
Christoph Bausch is the founder of Nanopore Diagnostics LLC.
Dr. Bausch is Chief Operating Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2017.
Dr. Bausch completed undergraduate studies at the University of Nebraska, earned an MBA from St. Louis University, and obtained a doctorate from The Ohio State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-02 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Verksamhetschef | 2022-05-01 |
| Företag | Position | Slut |
|---|---|---|
Nanopore Diagnostics LLC
 Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 5 |
|---|---|
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanopore Diagnostics LLC
Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
